Transcriptomic Mortality-risk Age

Biomarker

2 papers8 findings

  • Humans2

Associations

6

Limitations in activities of daily living

upin humans2

2 studies
  1. Transcriptomic Mortality-risk Age is associated with limitations in activities of daily living in humans.

    “TraMA was associated with earlier mortality, more chronic conditions, poorer cognitive functioning, and more limitations in activities of daily living.”

    Humansholdout test sample

    Development of a novel transcriptomic measure of aging: Transcriptomic Mortality-risk Age (TraMA)

    Aging13 Jun 2025

  2. Transcriptomic Mortality-risk Age is associated with limitations in activities of daily living in humans.

    “In a holdout test sample, TraMA was associated with earlier mortality, more chronic conditions, poorer cognitive functioning, and more limitations in activities of daily living.”

    Humansholdout test sample

    Development of a novel transcriptomic measure of aging: Transcriptomic Mortality-risk Age (TraMA)

    medRxiv : the preprint server for health sciences6 Dec 2024Preprint

Mortality

upin humans2

2 studies
  1. Transcriptomic Mortality-risk Age predicts mortality in humans.

    “In a holdout test sample, TraMA was associated with earlier mortality”

    Humansholdout test sample4 years

    Development of a novel transcriptomic measure of aging: Transcriptomic Mortality-risk Age (TraMA)

    Aging13 Jun 2025

  2. Transcriptomic Mortality-risk Age is associated with mortality in humans.

    “In a holdout test sample, TraMA was associated with earlier mortality, more chronic conditions, poorer cognitive functioning, and more limitations in activities of daily living.”

    Humansholdout test sample4 years

    Development of a novel transcriptomic measure of aging: Transcriptomic Mortality-risk Age (TraMA)

    medRxiv : the preprint server for health sciences6 Dec 2024Preprint

Cognitive functioning

downin humans1

1 study
  1. Transcriptomic Mortality-risk Age is associated with cognitive functioning in humans.

    “TraMA was associated with earlier mortality, more chronic conditions, poorer cognitive functioning”

    Humansholdout test sample

    Development of a novel transcriptomic measure of aging: Transcriptomic Mortality-risk Age (TraMA)

    Aging13 Jun 2025

Chronic condition burden

upin humans1

1 study
  1. Transcriptomic Mortality-risk Age is associated with chronic condition burden in humans.

    “TraMA was associated with earlier mortality, more chronic conditions”

    Humansholdout test sample

    Development of a novel transcriptomic measure of aging: Transcriptomic Mortality-risk Age (TraMA)

    Aging13 Jun 2025

Cognitive function

downin humans1

1 study
  1. Transcriptomic Mortality-risk Age is associated with cognitive function in humans.

    “In a holdout test sample, TraMA was associated with earlier mortality, more chronic conditions, poorer cognitive functioning, and more limitations in activities of daily living.”

    Humansholdout test sample

    Development of a novel transcriptomic measure of aging: Transcriptomic Mortality-risk Age (TraMA)

    medRxiv : the preprint server for health sciences6 Dec 2024Preprint

Number of chronic conditions

upin humans1

1 study
  1. Transcriptomic Mortality-risk Age is associated with number of chronic conditions in humans.

    “In a holdout test sample, TraMA was associated with earlier mortality, more chronic conditions, poorer cognitive functioning, and more limitations in activities of daily living.”

    Humansholdout test sample

    Development of a novel transcriptomic measure of aging: Transcriptomic Mortality-risk Age (TraMA)

    medRxiv : the preprint server for health sciences6 Dec 2024Preprint

Latest